KC-4336

293T-STAT5-Luc2-TPOR-Cell-Line

×
Please enable JavaScript in your browser to complete this form.
44414
Home » 293T-STAT5-Luc2-TPOR-Cell-Line

Background of 293T-STAT5-Luc2-TPOR-Cell-Line

MPL (MPL Proto-Oncogene, Thrombopoietin Receptor) is a Protein Coding gene. Diseases associated with MPL include Myelofibrosis and Thrombocythemia 2. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Integrin signaling. Gene Ontology (GO) annotations related to this gene include transmembrane signaling receptor activity and thrombopoietin receptor activity.Receptor for thrombopoietin that acts as a primary regulator of megakaryopoiesis and platelet production. May represent a regulatory molecule specific for TPO-R-dependent immune responses.

Specifications

Catalog NumberKC-4336
Cell Line Name293T-STAT5-Luc2-TPOR-Cell-Line
Host Cell Line293T-STAT5-Luc2
DescriptionStable 293T-STAT5-Luc2 cell line expressing exogenous TPOR gene
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% DMEM+20% FBS+10% DMSO
Propagation MediumDMEM+10% FBS +150μg/mL Hygromycin+1μg/mL Puromycin
Selection MarkerHygromycin and Puromycin
MorphologyEpithelial
SubcultureSplit saturated culture 1:4-1:5 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

293T-STAT5-Luc2-TPOR cell line was generated using lentivirus expressing TPOR sequence.

Characterization

Figure 1: 293T-STAT5-Luc2-TPOR cells were seeded into the 96-well plate, treated with TPO or Romiplostim 6 hours, then readout with Bright-lite™ Luciferase Assay system.

Cell Resuscitation

  1. Prewarm culture medium (DMEM supplemented with 10% FBS, 150μg/mL Hygromycin and 1μg/mL Puromycin)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Germeshausen M, Ballmaier M, Welte K. MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Hum Mutat. 2006 Mar;27(3):296. doi: 10.1002/humu.9415. PMID: 16470591.
  2. Bock O, Schlué J, Mengel M, Büsche G, Serinsöz E, Kreipe H. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders. J Pathol. 2004 May;203(1):609-15. doi: 10.1002/path.1558. PMID: 15095485.
Please enable JavaScript in your browser to complete this form.